Examination of a non-invasive biomarker for the diagnosis of prodromal Alzheimer's disease and Alzheimer's disease Dementia

Affiliations

¹ Biochemistry & Proteomics Group, Department of Chemistry and Biomolecular Science, Clarkson University, 8 Clarkson Avenue, Potsdam, NY, USA, 13699-5810.
² Biochemistry & Proteomics Group, Department of Chemistry and Biomolecular Science, Clarkson University, 8 Clarkson Avenue, Potsdam, NY, USA, 13699-5810; To whom inquiries should be addressed:. Electronic address: cdarie@clarkson.edu.

Comment

Emmalyn J Dupree et al. EBioMedicine. 2020 Jul.

. 2020 Jul:57:102882.

doi: 10.1016/j.ebiom.2020.102882. Epub 2020 Jul 7.

¹ Biochemistry & Proteomics Group, Department of Chemistry and Biomolecular Science, Clarkson University, 8 Clarkson Avenue, Potsdam, NY, USA, 13699-5810.
² Biochemistry & Proteomics Group, Department of Chemistry and Biomolecular Science, Clarkson University, 8 Clarkson Avenue, Potsdam, NY, USA, 13699-5810; To whom inquiries should be addressed:. Electronic address: cdarie@clarkson.edu.

No abstract available

Comment on

Decreased salivary lactoferrin levels are specific to Alzheimer's disease.
González-Sánchez M, Bartolome F, Antequera D, Puertas-Martín V, González P, Gómez-Grande A, Llamas-Velasco S, Herrero-San Martín A, Pérez-Martínez D, Villarejo-Galende A, Atienza M, Palomar-Bonet M, Cantero JL, Perry G, Orive G, Ibañez B, Bueno H, Fuster V, Carro E. González-Sánchez M, et al. EBioMedicine. 2020 Jul;57:102834. doi: 10.1016/j.ebiom.2020.102834. Epub 2020 Jun 22. EBioMedicine. 2020. PMID: 32586758 Free PMC article.

1. Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148–160. Epub 2019/02/10. - PMC - PubMed
1. Welling MM, Nabuurs RJ, van der Weerd L. Potential role of antimicrobial peptides in the early onset of Alzheimer's disease. Alzheimer's Dement. J. Alzheimer's Assoc. 2015;11(1):51–57. Epub 2014/03/19. - PubMed
1. Carro E, Bartolome F, Bermejo-Pareja F, Villarejo-Galende A, Molina JA, Ortiz P. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin. Alzheimers Dement (Amst) 2017;8:131–138. Epub 2017/06/27. - PMC - PubMed
1. Florian PE, Macovei A, Lazar C, Milac AL, Sokolowska I, Darie CC. Characterization of the anti-HBV activity of HLP1-23, a human lactoferrin-derived peptide. J Med Virol. 2013;85(5):780–788. Epub 2013/03/20. - PubMed
1. González-Sánchez M, Bartolome F, Antequera D, Puertas-Martín V, González P, Gómez-Grande A. Decreased salivary lactoferrin levels are specific to Alzheimer's disease. E Bio Med. 2020 doi: 10.1016/j.ebiom.2020.102834. - DOI - PMC - PubMed